Ajanta Pharma is planning to enhance its presence across select geographies with high growth potential in Asia and Africa, as part of its growth plans. It intends to rely on its strengths to grow faster in countries where it has a presence with its range of branded generics.
The company's branded generics business accounted for 73 per cent of its revenues in FY 2023, with Indian, rest of Asia and Africa contributing 31 per cent, 26 per cent and 15 per cent, respectively. In order to achieve its targets, it has enhanced capital allocation to branded generics businesses across India, the rest of Asia and Africa.
Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages.
